AVEO Oncology
AVEO
#7456
Rank
โ‚น49.51 B
Marketcap
โ‚น1,424
Share price
0.00%
Change (1 day)
189.77%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : โ‚น6.87 Billion

According to AVEO Oncology 's latest financial reports the company's total liabilities are โ‚น6.87 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31โ‚น4.42 B91.43%
2020-12-31โ‚น2.31 B-9.31%
2019-12-31โ‚น2.54 B-33.9%
2018-12-31โ‚น3.85 B-33.59%
2017-12-31โ‚น5.80 B192.62%
2016-12-31โ‚น1.98 B28.1%
2015-12-31โ‚น1.54 B-51.16%
2014-12-31โ‚น3.17 B-32.79%
2013-12-31โ‚น4.72 B-2.62%
2012-12-31โ‚น4.84 B28.14%
2011-12-31โ‚น3.78 B6.49%
2010-12-31โ‚น3.55 B6.38%
2009-12-31โ‚น3.33 B-58.83%
2008-12-31โ‚น8.11 B24.44%
2007-12-31โ‚น6.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
โ‚น10.292 T 149,654.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.971 T 115,873.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.257 T 18,188.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น951.32 B 13,740.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.201 T 90,129.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น2.15 B-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA